{
    "paper_id": "a766dcd7525f6bed936a3a58a7f18da2ced9317b",
    "metadata": {
        "title": "Use of ribavirin in viruses other than hepatitis C. A review of the evidence",
        "authors": [
            {
                "first": "German",
                "middle": [],
                "last": "Ram\u00edrez-Olivencia",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital Central de la Defensa G\u00f3mez Ulla",
                    "location": {
                        "settlement": "Madrid",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "Miriam",
                "middle": [],
                "last": "Est\u00e9banez",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital Central de la Defensa G\u00f3mez Ulla",
                    "location": {
                        "settlement": "Madrid",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "Francisco",
                "middle": [
                    "Javier"
                ],
                "last": "Membrillo",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital Central de la Defensa G\u00f3mez Ulla",
                    "location": {
                        "settlement": "Madrid",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "Maria",
                "middle": [],
                "last": "Del",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital Central de la Defensa G\u00f3mez Ulla",
                    "location": {
                        "settlement": "Madrid",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "Carmen",
                "middle": [],
                "last": "Ybarra",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital Central de la Defensa G\u00f3mez Ulla",
                    "location": {
                        "settlement": "Madrid",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "informaci\u00f3n del art\u00edculo Historia del art\u00edculo: Recibido el 16 de enero de 2018 Aceptado el 8 de mayo de 2018 On-line el 12 de junio de 2018",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Palabras clave: Ribavirina Virazole 1-f8-D-Ribofuranosil-1,2,4-triazol-3carboxamida r e s u m e n La ribavirina es una mol\u00e9cula con actividad antiviral sobre diferentes virus. Ha encontrado su hueco en la pr\u00e1ctica cl\u00ednica de forma casi exclusiva para el tratamiento del virus de la hepatitis C, pero existen otras enfermedades que podr\u00edan beneficiarse de su empleo. Su disponibilidad para administraci\u00f3n por v\u00eda oral, por v\u00eda intravenosa e inhalada es una caracter\u00edstica beneficiosa. En este trabajo se realiza una revisi\u00f3n de las indicaciones en las principales agencias del medicamento (espa\u00f1ola, europea y americana), as\u00ed como de otras posibles indicaciones, principalmente sobre fiebres hemorr\u00e1gicas y coronavirus.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral, intravenous and inhaled administration. We conducted a review of the indications of the main drug agencies (Spanish, European and American) and other possible indications, mainly haemorrhagic fevers and coronavirus.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "estomatitis vesicular y Semliki Forest). Posteriormente se conoci\u00f3 su actividad sobre otras enfermedades virales y ha encontrado su hueco en la pr\u00e1ctica cl\u00ednica de forma casi exclusiva para el tratamiento del virus de la hepatitis C (VHC).",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "En el presente trabajo se ha realizado una revisi\u00f3n de la bibliograf\u00eda sobre la base de datos Pubmed (hasta el 31 de diciembre de 2017) cruzando (en ingl\u00e9s) la palabra clave \u00abribavirin\u00bb con las correspondientes a los virus o enfermedades siguientes: adenovirus, hantavirus, syncytial respiratory virus, Lassa fever, Crimean Congo hemorrhagic fever, Argentinian hemorrhagic fever y coronavirus. Se han revisado los art\u00edculos escritos en ingl\u00e9s o en castellano, seleccion\u00e1ndose de forma preferente para cada enfermedad los metaan\u00e1lisis; en caso de que no existieran, se han revisado los ensayos cl\u00ednicos fase I, II, III y IV. Finalmente, si no se encontraban en las b\u00fasquedas previas, se realizaba una revisi\u00f3n de los casos o series de casos publicadas. De los art\u00edculos revisados, se obten\u00edan en algunos casos referencias a otros trabajos. https://doi.org/10.1016/j.eimc.2018.05.008 0213-005X/\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Todos los derechos reservados.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Se han propuesto diferentes mecanismos de acci\u00f3n para esta mol\u00e9cula, y lo m\u00e1s probable es que act\u00fae de diversas formas en virus diferentes 2 . El primer mecanismo que se ha planteado es la interferencia en la s\u00edntesis de novo de los derivados de la guanosina (especialmente guanos\u00edn trifosfato [GTP] ). La inosina monofosfato deshidrogenasa cataliza la formaci\u00f3n de xantina monofosfato a partir de la inosina monofosfato, para posteriormente continuar la v\u00eda de s\u00edntesis de los derivados de la guanosina. La ribavirina monofosfato es capaz de inhibir de forma competitiva y potente dicha enzima, disminuyendo las reservas de estos nucle\u00f3tidos (o nucle\u00f3sidos) a la mitad en las c\u00e9lulas tratadas. La actividad antiviral paralela a la depleci\u00f3n de reservas de GTP se ha demostrado en estudios con el virus de la fiebre amarilla y paramyxovirus como el virus respiratorio sincitial (VRS). En segundo lugar, se ha sugerido una actividad inmunomoduladora, indicando que la ribavirina pudiera aumentar la actividad de los linfocitos T, y especialmente de los linfocitos Th. Esta hip\u00f3tesis se basaba en la observaci\u00f3n de que durante el tratamiento con ribavirina en pacientes infectados por VHC pod\u00eda disminuir la cit\u00f3lisis sin modificar la carga viral circulante; por tanto, no tendr\u00eda un efecto exclusivamente antiviral. Apoyaba esta hip\u00f3tesis la observaci\u00f3n de que un enanti\u00f3mero de la ribavirina (levovirina) no presenta actividad antiviral directa, siendo capaz tambi\u00e9n de producir una inducci\u00f3n de la respuesta Th1 en el modelo murino. Sin embargo, el efecto inmunomodulador no se ha podido reconocer in vivo, e incluso en modelos matem\u00e1ticos dise\u00f1ados al respecto se concluye que el efecto se basa en actividad antiviral directa. Otro mecanismo que se ha propuesto es el de la inhibici\u00f3n directa de la polimerasa. El principal metabolito intracelular de la ribavirina es el ribavir\u00edn trifosfato (RTP). De esta forma, podr\u00eda ser un inhibidor competitivo de otras bases nitrogenadas similares, como adenos\u00edn trifosfato (ATP) o GTP. Este efecto se ha observado en estudios realizados con virus gripal, reovirus y el virus de la estomatitis vesicular. Algunos virus RNA contienen una estructura con 7-metilguanosina, que es esencial para la estabilidad del RNA y que est\u00e1 sintetizada en tres procesos catal\u00edticos diferentes. En otros virus, el proceso de traslaci\u00f3n est\u00e1 mediado por una mol\u00e9cula conocida como eIF4E. La mol\u00e9cula de ribavirina podr\u00eda interaccionar con las enzimas responsables del capping (s\u00edntesis de caperuza del RNA) o unirse a eIF4E impidiendo el inicio de la traslaci\u00f3n. Este mecanismo podr\u00eda ser el responsable de la actividad antiviral observada en algunos virus (Lassa, SARS). Por \u00faltimo, se ha propuesto un mecanismo de mutag\u00e9nesis. Dada la similitud estructural, la incorporaci\u00f3n de ribavirina en la cadena de RNA ser\u00eda posible y producir\u00eda virus mutantes durante la replicaci\u00f3n. Pero no solo alterar\u00eda la cadena \u00aboriginal\u00bb sustituyendo una GTP por RTP, sino que la uni\u00f3n a las bases complementarias citidina y timidina (o uracilo) tiene la misma eficacia. Esto se debe a la disposici\u00f3n espacial y a la flexibilidad en la rotaci\u00f3n de un grupo carboxamida. El efecto mutag\u00e9nico de la ribavirina se ha demostrado en estudios con poliovirus, virus boca-mano-pie, West Nile y hantavirus.",
            "cite_spans": [
                {
                    "start": 294,
                    "end": 299,
                    "text": "[GTP]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Mecanismo de acci\u00f3n"
        },
        {
            "text": "Como se ha comentado anteriormente, el empleo cl\u00ednico de la ribavirina est\u00e1 casi exclusivamente limitado al tratamiento de la infecci\u00f3n por el VHC. Sin embargo, cuando se realiza una revisi\u00f3n de las indicaciones en las principales agencias del medicamento (Agencia Espa\u00f1ola del Medicamento, Agencia Europea del Medicamento y Food and Drug Administration [FDA] estadounidense), pueden encontrarse otras indicaciones aprobadas menos conocidas.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Indicaciones en ficha t\u00e9cnica"
        },
        {
            "text": "En la p\u00e1gina web de la Agencia Espa\u00f1ola del Medicamento 3 se encuentra el f\u00e1rmaco Virazole, en forma de viales para inhalaci\u00f3n respiratoria. No se hace menci\u00f3n a la indicaci\u00f3n espec\u00edfica, indic\u00e1ndose que el f\u00e1rmaco no est\u00e1 comercializado actualmente en Espa\u00f1a y que existen problemas con el suministro. Se empleaba en aerosol en ni\u00f1os con infecci\u00f3n grave del tracto respiratorio inferior causado por VRS. El tratamiento consist\u00eda en su nebulizaci\u00f3n durante 12-18 h por un per\u00edodo de 3 a 7 d\u00edas.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Indicaciones en ficha t\u00e9cnica"
        },
        {
            "text": "En la Agencia Europea del Medicamento 4 se encuentra tambi\u00e9n, aparte de la indicaci\u00f3n para VHC, dos aplicaciones de la ribavirina que han sido investigadas: infecciones por adenovirus e infecciones por hantavirus. En ambos casos la decisi\u00f3n adoptada ha sido la retirada de su consideraci\u00f3n en estas indicaciones.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Indicaciones en ficha t\u00e9cnica"
        },
        {
            "text": "Por \u00faltimo, en la FDA 5 se indica la aprobaci\u00f3n de Virazole para nebulizaci\u00f3n, aunque no especifica las enfermedades.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Indicaciones en ficha t\u00e9cnica"
        },
        {
            "text": "A continuaci\u00f3n se revisa la evidencia cl\u00ednica de la efectividad de ribavirina para tratar la infecci\u00f3n por VRS, adenovirus y hantavirus.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Indicaciones en ficha t\u00e9cnica"
        },
        {
            "text": "Existe un metaan\u00e1lisis realizado por la Cochrane Database System Review 6 en relaci\u00f3n con el uso de ribavirina en infecciones respiratorias bajas en ni\u00f1os y adolescentes, con dos actualizaciones posteriores y una retirada en 2010. La \u00faltima revisi\u00f3n consiste, pues, en la publicada en 2007. En ella se llega a la conclusi\u00f3n de que, tras analizar 12 ensayos cl\u00ednicos, la ribavirina no es eficaz en la reducci\u00f3n de la mortalidad ni en el desarrollo de deterioro respiratorio; no obstante, se observa una reducci\u00f3n de la estancia hospitalaria y de d\u00edas de ventilaci\u00f3n mec\u00e1nica (aproximadamente 2 d\u00edas en ambos casos).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Virus respiratorio sincitial"
        },
        {
            "text": "Otro aspecto diferente de la utilizaci\u00f3n de ribavirina en trasplantados era el tratamiento de infecciones respiratorias por VRS. Shah y Chemaly 7 realizaron una revisi\u00f3n de la literatura acerca de los trabajos realizados en adultos trasplantados con infecci\u00f3n por VRS y publicados entre 1980 y 2010. Evaluaron 26 estudios tanto prospectivos como retrospectivos (ensayos cl\u00ednicos aleatorizados y observacionales) cuya variable principal fuera la mortalidad atribuida a VRS o progresi\u00f3n de la enfermedad. En estos trabajos aparec\u00eda el empleo de ribavirina en cualquier forma (aerosolizada, oral o intravenosa). La conclusi\u00f3n global es que el empleo de ribavirina (asociada o no a inmunoglobulinas) disminu\u00eda la progresi\u00f3n a enfermedad de v\u00edas bajas y disminu\u00eda la mortalidad. La ribavirina inhalada era \u00fatil, pero sobre todo era m\u00e1s efectiva asociada a inmunoglobulina, aunque su difusi\u00f3n en el par\u00e9nquima consolidado pod\u00eda estar disminuida. El coste era el principal inconveniente de esta terapia (aproximadamente 50.000$ por paciente).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Virus respiratorio sincitial"
        },
        {
            "text": "En primer lugar hay que destacar que, cuando se revisa la literatura publicada (109 art\u00edculos en Pubmed), no existen metaan\u00e1lisis ni ensayos cl\u00ednicos. La evidencia cient\u00edfica est\u00e1 disponible a partir de series de casos y casos aislados. Existen 7 series de casos publicadas 8-14 y 21 casos aislados , lo que supone en total una experiencia publicada sobre menos de 150 casos (tablas 1 y 2). Como se puede observar, existe heterogeneidad tanto por parte del virus tratado (serotipos) como en las caracter\u00edsticas de los pacientes (edad, sexo, factores de riesgo) como en los s\u00edndromes producidos (neumon\u00eda, cistitis, enfermedad digestiva, focal/diseminada), tiempo de evoluci\u00f3n de enfermedad, combinaci\u00f3n con otros f\u00e1rmacos. . . Por tanto, no se puede obtener ninguna conclusi\u00f3n, y por ello hasta la fecha su uso no ha sido aprobado.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Adenovirus"
        },
        {
            "text": "Respecto al empleo de ribavirina en las enfermedades producidas por hantavirus, existe un metaan\u00e1lisis publicado en 2014 por Moreli et al. 36 revisi\u00f3n sistem\u00e1tica en la que se identifican 518 estudios; tras aplicar los criterios de exclusi\u00f3n solo se pueden analizar 7 estudios, lo que supone un total de 506 pacientes. Se distinguen 2 grupos (fiebre hemorr\u00e1gica con s\u00edndrome renal y s\u00edndrome pulmonar por hantavirus), adem\u00e1s de dos subgrupos (estudios realizados en animales [4] o en humanos [3] ). La mortalidad global era del 35%. En el grupo de s\u00edndrome pulmonar por hantavirus se identifican un estudio aleatorizado y 3 cohortes prospectivas. En los estudios animales se observ\u00f3 una reducci\u00f3n de la mortalidad en el grupo de tratamiento frente a placebo, pero no en los estudios en humanos, con una mortalidad en ambos grupos del 40%. En el grupo de fiebre hemorr\u00e1gica con s\u00edndrome renal se incluyeron 3 estudios. Tanto en el subgrupo de animales como en el de humanos s\u00ed se observ\u00f3 una reducci\u00f3n en la mortalidad cuando se utilizaba ribavirina respecto a placebo (2,5% frente al 8,5% de mortalidad) con un riesgo relativo (RR) de 0,56 (0,42-0,76).",
            "cite_spans": [
                {
                    "start": 139,
                    "end": 141,
                    "text": "36",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 475,
                    "end": 478,
                    "text": "[4]",
                    "ref_id": null
                },
                {
                    "start": 492,
                    "end": 495,
                    "text": "[3]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Hantavirus"
        },
        {
            "text": "Con los datos existentes en este metaan\u00e1lisis podr\u00eda sugerirse que las infecciones por hantavirus del viejo mundo (fiebre hemorr\u00e1gica con s\u00edndrome renal) podr\u00edan beneficiarse del empleo de ribavirina, mientras que en el s\u00edndrome pulmonar por hantavirus no ser\u00eda \u00fatil. Los autores ya indican que no se ha podido considerar el tiempo desde el diagn\u00f3stico hasta la administraci\u00f3n de la ribavirina: el s\u00edndrome pulmonar por hantavirus tiene una mortalidad del 50% y puede indicar una m\u00e1s r\u00e1pida progresi\u00f3n de la enfermedad que en la fiebre hemorr\u00e1gica con s\u00edndrome renal, cuya mortalidad es del 15%. Esto ser\u00eda un factor clave, indicando la mayor necesidad de iniciar de forma temprana la terapia.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Hantavirus"
        },
        {
            "text": "Otro sesgo puede haber sido la restricci\u00f3n de trabajos seleccionados seg\u00fan el idioma: solo se seleccionaron trabajos publicados en ingl\u00e9s, espa\u00f1ol o portugu\u00e9s. Dado que China es el pa\u00eds que m\u00e1s casos tiene de hantavirus con fiebre hemorr\u00e1gica (en el periodo 1950-2007 se han notificado un total de 1.557.622 casos de fiebre hemorr\u00e1gica con s\u00edndrome renal, con clara tendencia a disminuir la incidencia), es posible que se haya eliminado a priori informaci\u00f3n publicada en chino que modificase los resultados obtenidos.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Hantavirus"
        },
        {
            "text": "Por \u00faltimo, hay que considerar que el listado de hantavirus es extenso (23, que incluyen entre otros el virus Hantaan, Seoul, Puumala y Dovabra para fiebre hemorr\u00e1gica con s\u00edndrome renal, y Sinnombre y Andes en el s\u00edndrome pulmonar por hantavirus). La heterogeneidad entre virus (no solo entre s\u00edndromes) puede condicionar los resultados. Esto es lo que puede se\u00f1alar un trabajo reciente realizado para evaluar la eficacia y la seguridad de la ribavirina en el tratamiento de la fiebre hemorr\u00e1gica con s\u00edndrome renal producida por el virus Puumala 37 , que no encuentra beneficio del uso de ribavirina. Se trata de un estudio aleatorizado abierto, sobre 73 pacientes, de los que 36 reciben terapia est\u00e1ndar de soporte y 37 la misma terapia adem\u00e1s de ribavirina intravenosa; el estudio no ha sido capaz de mostrar eficacia ni en aspectos cl\u00ednicos ni de cin\u00e9tica viral en el tratamiento, con importantes efectos secundarios (principalmente anemia, hiperbilirrubinemia, bradicardia sinusal y rash cut\u00e1neo).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Hantavirus"
        },
        {
            "text": "Cuando se realiza una revisi\u00f3n del tratamiento de la fiebre de Lassa con ribavirina se obtienen 108 publicaciones; sin embargo, cuando se eval\u00faan los ensayos cl\u00ednicos y metaan\u00e1lisis se obtiene solo una referencia en relaci\u00f3n con la efectividad del tratamiento 38 . Se trata de un estudio desarrollado en Sierra Leona en 1986 por parte del Ministerio de Salud en colaboraci\u00f3n con el Centro de Control (CDC), que comenz\u00f3 en 1977 y en el que se evalu\u00f3 la administraci\u00f3n de plasma de convaleciente, ribavirina oral y ribavirina intravenosa. El estudio es algo complejo pero, a pesar de ello, se puede concluir que se recomienda el tratamiento con ribavirina intravenosa u oral en cualquier momento de la enfermedad (siendo m\u00e1s efectivo en los primeros 6 d\u00edas de enfermedad). Inicialmente se dise\u00f1\u00f3 un estudio fase I de casos y control de los aspectos cl\u00ednicos y diagn\u00f3sticos de la fiebre de Lassa en pacientes no tratados (se recogieron 30 variables cl\u00ednicas y de laboratorio que fueron analizadas posteriormente), y una vez recogidas dichas variables se realiz\u00f3 un ensayo aleatorizado con 70 pacientes (39 con ribavirina oral y 31 con plasma; las mujeres embarazadas entraban sin aleatorizar en este \u00faltimo grupo), desconoci\u00e9ndose en ese momento los resultados del an\u00e1lisis de las variables recogidas. En todos los casos el tratamiento se inici\u00f3 en las primeras 24 h. Como variables de mal pron\u00f3stico se identificaron, a posteriori, la elevaci\u00f3n de transaminasas y la viremia mayor de 1.000 copias/ml.",
            "cite_spans": [
                {
                    "start": 260,
                    "end": 262,
                    "text": "38",
                    "ref_id": "BIBREF37"
                }
            ],
            "ref_spans": [],
            "section": "Fiebre de Lassa"
        },
        {
            "text": "Posteriormente, conocidas las variables indicadoras de mal pron\u00f3stico, se desarroll\u00f3 un estudio fase II, seleccionando los pacientes con una de las variables de mal pron\u00f3stico (elevaci\u00f3n de transaminasas al diagn\u00f3stico; la viremia no estaba disponible). Se aleatorizaron dos grupos de pacientes (29 pacientes en grupo de ribavirina intravenosa y 33 en grupo de ribavirina intravenosa m\u00e1s plasma; las embarazadas recibieron solo 2 unidades de plasma). De forma global (an\u00e1lisis de los pacientes incluidos tanto en el estudio fase I como en el fase II), el tratamiento con ribavirina disminu\u00eda la mortalidad. En los pacientes con viremia > 1.000 copias/ml y tratados con ribavirina la mortalidad era menor que en los que estaban sin tratamiento (mortalidad con ribavirina intravenosa del 32% frente al 76% sin terapia (p = 0,00015); mortalidad con ribavirina oral del 30% frente al 76% sin terapia (p = 0,008). Lo mismo ocurr\u00eda si la viremia era < 1.000 copias/ml (mortalidad con ribavirina intravenosa del 9% frente al 28% sin terapia (p = 0,02); mortalidad con ribavirina oral del 7% frente al 28% sin terapia (p = 0,01).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Fiebre de Lassa"
        },
        {
            "text": "Existe un segundo trabajo, realizado por Fisher-Hoch et al. 39 , que aparece en Pubmed como ensayo cl\u00ednico con relaci\u00f3n al empleo de ribavirina en la fiebre de Lassa. Si bien es verdad que hace referencia a su empleo en un ensayo cl\u00ednico, lo que describe es la aparici\u00f3n de un efecto adverso que se asociaba a curaci\u00f3n (\u00abtiritona/escalofr\u00edos\u00bb) y que parec\u00eda estar en relaci\u00f3n con la velocidad de administraci\u00f3n del f\u00e1rmaco (< 1 min). Tras corregir la velocidad de infusi\u00f3n desaparecieron estos efectos secundarios. Se ha realizado alg\u00fan estudio para la evaluaci\u00f3n de la ribavirina como profilaxis postexposici\u00f3n, pero no ha aportado resultados concluyentes [40] [41] .",
            "cite_spans": [
                {
                    "start": 60,
                    "end": 62,
                    "text": "39",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 657,
                    "end": 661,
                    "text": "[40]",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 662,
                    "end": 666,
                    "text": "[41]",
                    "ref_id": "BIBREF40"
                }
            ],
            "ref_spans": [],
            "section": "Fiebre de Lassa"
        },
        {
            "text": "Existe un solo ensayo cl\u00ednico aleatorizado que eval\u00faa la utilidad de la ribavirina para la fiebre hemorr\u00e1gica Crimea-Congo, realizado entre 2004 y 2007 con 136 pacientes 42 . De forma basal, no exist\u00edan diferencias en el sexo, edad, per\u00edodo de incubaci\u00f3n (alrededor de 5 d\u00edas), caracter\u00edsticas cl\u00ednicas o anal\u00edticas. La administraci\u00f3n de la ribavirina se hac\u00eda antes de confirmar el diagn\u00f3stico, por lo que el tiempo hasta la administraci\u00f3n de la misma fue alrededor de 4 d\u00edas. No se encontraron diferencias en cuanto a mortalidad, recuperaci\u00f3n anal\u00edtica o tiempo de estancia hospitalaria. Posteriormente, 2 metaan\u00e1lisis eval\u00faan la utilidad de la ribavirina para la fiebre hemorr\u00e1gica Crimea-Congo. El primero es del a\u00f1o 2010 43 y revisa 21 trabajos. La conclusi\u00f3n que extraen los autores es que la ribavirina en el ensayo cl\u00ednico no fue superior al no empleo de la misma, pero en la evaluaci\u00f3n conjunta de todos los resultados s\u00ed redujo la mortalidad (RR: 0,56; IC 95%: 0,35-0,90; 955 participantes). Lo que no se encontr\u00f3 fue diferencia en la duraci\u00f3n del ingreso hospitalario. El segundo metaan\u00e1lisis es del a\u00f1o 2011 44 , e incluye tambi\u00e9n el \u00fanico ensayo cl\u00ednico aleatorizado, pero solo introduce 7 trabajos m\u00e1s que son observacionales con grupo control. Tampoco se encuentra beneficio de la ribavirina con los datos agregados. En ambos metaan\u00e1lisis se insiste en el riesgo de sesgo en todos los trabajos, ya sea de selecci\u00f3n, de validez externa o de atrici\u00f3n. ",
            "cite_spans": [
                {
                    "start": 170,
                    "end": 172,
                    "text": "42",
                    "ref_id": "BIBREF41"
                }
            ],
            "ref_spans": [],
            "section": "Fiebre hemorr\u00e1gica Crimea-Congo"
        },
        {
            "text": "La ribavirina no ha conseguido demostrar su utilidad en la reducci\u00f3n de la mortalidad por el virus Junin (fiebre hemorr\u00e1gica argentina) en 2 ensayos cl\u00ednicos muy reducidos 45, 46 . No obstante, en el primer trabajo se observ\u00f3 bloqueo de la replicaci\u00f3n viral y un retraso en el tiempo hasta el fallecimiento, comparado con controles hist\u00f3ricos. El aclaramiento de la viremia se consigui\u00f3 incluso en los pacientes que fallecieron (en esta fase de la enfermedad se detecta el virus hasta en el 80% de los casos). Dado que existe un tratamiento que ha mostrado ser eficaz si se administra en los primeros 7 d\u00edas de enfermedad (suero de convaleciente), los estudios que emplearon ribavirina se realizaron en fases avanzadas de la enfermedad, lo que justificar\u00eda los malos resultados. Probablemente no sea posible realizar nuevos estudios al respecto, dado que existe tambi\u00e9n una vacuna que ha resultado eficaz en la reducci\u00f3n de la incidencia de la enfermedad 47 .",
            "cite_spans": [
                {
                    "start": 172,
                    "end": 175,
                    "text": "45,",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 176,
                    "end": 178,
                    "text": "46",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 955,
                    "end": 957,
                    "text": "47",
                    "ref_id": "BIBREF46"
                }
            ],
            "ref_spans": [],
            "section": "Fiebres hemorr\u00e1gicas sudamericanas"
        },
        {
            "text": "Pr\u00e1cticamente no existen casos comunicados de virus Machupo tratados con ribavirina (fiebre hemorr\u00e1gica boliviana): tan solo 2 casos aislados en los que se administr\u00f3 ribavirina intravenosa y se recuperaron 48 . Lo mismo ocurre con los casos de virus Sabia. En 1995, un caso de virus Sabia fue tratado con ribavirina intravenosa, consiguiendo la curaci\u00f3n del paciente 49 .",
            "cite_spans": [
                {
                    "start": 207,
                    "end": 209,
                    "text": "48",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 368,
                    "end": 370,
                    "text": "49",
                    "ref_id": "BIBREF48"
                }
            ],
            "ref_spans": [],
            "section": "Fiebres hemorr\u00e1gicas sudamericanas"
        },
        {
            "text": "Se ha realizado un estudio retrospectivo en 44 pacientes con coronavirus 50 para comparar la combinaci\u00f3n de interfer\u00f3n y ribavirina frente a placebo, observ\u00e1ndose una mejor\u00eda en la supervivencia a los 14 (70% vs 29%) y 28 d\u00edas (30% vs 17%) a favor de la combinaci\u00f3n de f\u00e1rmacos, aunque la diferencia a 28 d\u00edas no fue estad\u00edsticamente significativa (probablemente por el peque\u00f1o tama\u00f1o muestral). La media de inicio de tratamiento con ribavirina era de 3 d\u00edas. Adem\u00e1s, se han comunicado casos aislados 51-55 y series de casos [56] [57] [58] [59] [60] que reflejan grados variables de \u00e9xito terap\u00e9utico (tablas 3 y 4).",
            "cite_spans": [
                {
                    "start": 525,
                    "end": 529,
                    "text": "[56]",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 530,
                    "end": 534,
                    "text": "[57]",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 535,
                    "end": 539,
                    "text": "[58]",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 540,
                    "end": 544,
                    "text": "[59]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 545,
                    "end": 549,
                    "text": "[60]",
                    "ref_id": "BIBREF59"
                }
            ],
            "ref_spans": [],
            "section": "Virus respiratorios: coronavirus"
        },
        {
            "text": "Actualmente se investigan nuevas aplicaciones de la ribavirina. Est\u00e1n registrados 4 estudios para investigar su utilidad en gripe, 3 sobre arbovirosis, 3 sobre hepatitis B, 3 sobre hantavirus, 2 sobre paramyxovirus, 2 en virus Coxsackie y uno en coronavirus.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Estudios en ribavirina"
        },
        {
            "text": "La ribavirina es un antiviral de amplio espectro que actualmente busca un nuevo papel en el tratamiento de diversas infecciones. Su disponibilidad para administraci\u00f3n v\u00eda oral, por v\u00eda intravenosa e inhalada es una caracter\u00edstica beneficiosa. Existe evidencia de beneficio en la infecci\u00f3n por VRS y fiebre de Lassa, pudiendo plantearse su uso en determinadas situaciones en enfermedad por hantavirus, fiebre hemorr\u00e1gica Crimea-Congo y coronavirus como MERS-CoV. Actualmente existe en Espa\u00f1a la disponibilidad de ribavirina en formulaci\u00f3n oral, mientras que las formas inhalada e intravenosa se deben solicitar a trav\u00e9s de la Agencia Espa\u00f1ola del Medicamento.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusi\u00f3n"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Broadspectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Sidwell",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Huffman",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "P"
                    ],
                    "last": "Khare",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "B"
                    ],
                    "last": "Allen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Witkowski",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Robins",
                    "suffix": ""
                }
            ],
            "year": 1972,
            "venue": "Science",
            "volume": "177",
            "issn": "",
            "pages": "705--711",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Mechanisms of action of ribavirin against distinct viruses",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Graci",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Cameron",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Rev Med Virol",
            "volume": "16",
            "issn": "",
            "pages": "37--48",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "U S Food and Drug Administration Home Page",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ventre",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Randolph",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Cochrane Database Syst Rev",
            "volume": "12",
            "issn": "5",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Management of RSV infections in recipients of hematopoietic stem cell transplantation",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "N"
                    ],
                    "last": "Shah",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "F"
                    ],
                    "last": "Chemaly",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Blood",
            "volume": "117",
            "issn": "",
            "pages": "2755--64",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Gavin",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "Z"
                    ],
                    "last": "Katz",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Pediatrics",
            "volume": "110",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Miyamura",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hamaguchi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Taji",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kanie",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kohno",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tanimoto",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Bone Marrow Transplant",
            "volume": "25",
            "issn": "",
            "pages": "545--553",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: A multicenter case series",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Fu",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Tong",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Walline",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "PLoS One",
            "volume": "11",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Qu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Clin Virol",
            "volume": "54",
            "issn": "",
            "pages": "295--301",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Omar",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Yun",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Lewensohn-Fuchs",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "P\u00e9rez-Bercoff",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "\u00d6rvell",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Engstr\u00f6m",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Transpl Infect Dis",
            "volume": "12",
            "issn": "",
            "pages": "465--474",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schleuning",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Buxbaum-Conradi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "J\u00e4ger",
                    "suffix": ""
                },
                {
                    "first": "H-J",
                    "middle": [],
                    "last": "Kolb",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Hematol J",
            "volume": "5",
            "issn": "",
            "pages": "135--179",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bordigoni",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Carret",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Venard",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Witz",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Faou",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Clin Infect Dis",
            "volume": "32",
            "issn": "",
            "pages": "1290--1297",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Severe community-acquired adenovirus pneumonia treated with oral ribavirin: A case report",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "W"
                    ],
                    "last": "Yoon",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "G"
                    ],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "BMC Res Notes",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Successful treatment of disseminated adenovirus infection with ribavirin and intravenous immunoglobulin in an adult renal transplant recipient: A case report",
            "authors": [
                {
                    "first": "U",
                    "middle": [
                        "J"
                    ],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Hyun",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Han",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Transplant Proc",
            "volume": "47",
            "issn": "",
            "pages": "791--794",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Fever, haematuria, and acute graft dysfunction in renal transplant recipients secondary to adenovirus infection: Two case reports",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ramirez",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "C"
                    ],
                    "last": "Bostock",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Martin-Onraet",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Calleja",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sanchez-Cedillo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Navarro-Vargas",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Case Rep Nephrol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Disseminated adenovirus disease in immunocompromised patient successfully treated with oral ribavirin: A case report",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "E"
                    ],
                    "last": "Ulrych",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dzieci\u0105tkowski",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Przybylski",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zdu\u0144czyk",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Boguradzki",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Torosian",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Arch Immunol Ther Exp (Warsz)",
            "volume": "59",
            "issn": "",
            "pages": "473--480",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Abe",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Miyamura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Oba",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Terakura",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kasai",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kitaori",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Bone Marrow Transplant",
            "volume": "32",
            "issn": "",
            "pages": "1107--1115",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: Successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "E"
                    ],
                    "last": "Emovon",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "N"
                    ],
                    "last": "Howell",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Afzal",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baillie",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Rogers",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nephrol Dial Transplant",
            "volume": "18",
            "issn": "",
            "pages": "2436--2444",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Arav-Boger",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Echavarria",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Forman",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Charache",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Persaund",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Pediatr Infect Dis J",
            "volume": "19",
            "issn": "",
            "pages": "1097--100",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Intravenous ribavirin therapy for adenovirus pneumonia",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Shetty",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Gans",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "So",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Millan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Arvin",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Gutierrez",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Pediatr Pulmonol",
            "volume": "29",
            "issn": "",
            "pages": "69--73",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: Failure of intravenous ribavirin therapy",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chakrabarti",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "E"
                    ],
                    "last": "Collingham",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Fegan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Milligan",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Bone Marrow Transplant",
            "volume": "23",
            "issn": "",
            "pages": "1209--1220",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Adenovirus pneumonitis successfully treated with intravenous ribavirin",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Jurado Chac\u00f3n",
                    "suffix": ""
                },
                {
                    "first": "Hern\u00e1ndez",
                    "middle": [],
                    "last": "Mohedo",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Navarro",
                    "middle": [],
                    "last": "Mar\u00ed",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Ferrer",
                    "middle": [],
                    "last": "Chaves",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Escobar",
                    "middle": [],
                    "last": "Vedia",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "De Pablos Gallego",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Haematologica",
            "volume": "83",
            "issn": "",
            "pages": "1128--1137",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: A case report",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Mann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Moreb",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "Gian",
                    "middle": [
                        "V"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Infect",
            "volume": "36",
            "issn": "",
            "pages": "227--235",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Ribavirin therapy for adenovirus pneumonia in an AIDS patient",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Maslo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Girard",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Urban",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Guessant",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Rozenbaum",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Am J Respir Crit Care Med",
            "volume": "156",
            "issn": "",
            "pages": "1263--1267",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: Pharmacokinetics and clearance by hemofiltration",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Aebi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Headrick",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "H"
                    ],
                    "last": "Mccracken",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Lindsay",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Pediatr",
            "volume": "130",
            "issn": "",
            "pages": "612--617",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Sabroe",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mchale",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Tait",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "A"
                    ],
                    "last": "Lynn",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "N"
                    ],
                    "last": "Ward",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shaunak",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Thorax",
            "volume": "50",
            "issn": "",
            "pages": "1219--1239",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kapelushnik",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Or",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Delukina",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nagler",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Livni",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Engelhard",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Pediatr Gastroenterol Nutr",
            "volume": "21",
            "issn": "",
            "pages": "110--112",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Adenovirusassociated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Jurado",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Navarro",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hern\u00e1ndez",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Molina",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Depablos",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Bone Marrow Transplant",
            "volume": "15",
            "issn": "",
            "pages": "651--653",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Recovery from adenovirus pneumonia in a severe combined immunodeficiency patient treated with intravenous ribavirin",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "M"
                    ],
                    "last": "Wulffraat",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "P"
                    ],
                    "last": "Geelen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Van Dijken",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "De Graeff-Meeder",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Kuis",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Boven",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Transplantation",
            "volume": "59",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "F"
                    ],
                    "last": "Cassano",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Bone Marrow Transplant",
            "volume": "7",
            "issn": "",
            "pages": "247--255",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Adenovirusassociated hemorrhagic cystitis treated with intravenous ribavirin",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "F"
                    ],
                    "last": "Murphy",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "P"
                    ],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Mcroberts",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Henslee-Downey",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "J Urol",
            "volume": "149",
            "issn": "",
            "pages": "565--571",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Severe adenoviral nephritis following bone marrow transplantation: Successful treatment with intravenous ribavirin",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Liles",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cushing",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Holt",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bryan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Hackman",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Bone Marrow Transplant",
            "volume": "12",
            "issn": "",
            "pages": "409--421",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Hromas",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Clark",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Blanke",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Tricot",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Cornetta",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hedderman",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Bone Marrow Transplant",
            "volume": "14",
            "issn": "",
            "pages": "663--667",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Effectiveness of the ribavirin in treatment of hantavirus infections in the Americas and Eurasia: A meta-analysis",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Moreli",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Marques-Silva",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "A"
                    ],
                    "last": "Pimentel",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "G"
                    ],
                    "last": "Da Costa",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Virusdisease",
            "volume": "25",
            "issn": "",
            "pages": "385--394",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "V"
                    ],
                    "last": "Malinin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "E"
                    ],
                    "last": "Platonov",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Infect Dis (Auckl)",
            "volume": "49",
            "issn": "",
            "pages": "514--534",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Lassa fever effective therapy with ribavirin",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Mccormick",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "J"
                    ],
                    "last": "King",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Webb",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Scribner",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Craven",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "N Engl J Med",
            "volume": "314",
            "issn": "",
            "pages": "20--26",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Unexpected adverse reactions during a clinical trial in rural West Africa",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "P"
                    ],
                    "last": "Fisher-Hoch",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gborie",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Parker",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Huggins",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Antiviral Res",
            "volume": "19",
            "issn": "",
            "pages": "139--186",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Ribavirin for Lassa Fever postexposure prophylaxis",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Hadi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Goba",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bangura",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sankoh",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Koroma",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Emerg Infect Dis",
            "volume": "16",
            "issn": "",
            "pages": "2009--2020",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Isa",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Okwute",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "O"
                    ],
                    "last": "Iraoyah",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Nathan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Simji",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "O"
                    ],
                    "last": "Okolo",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Niger Med J",
            "volume": "57",
            "issn": "",
            "pages": "246--50",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Koksal",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yilmaz",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Aksoy",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Aydin",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Yavuz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Iskender",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Clin Virol",
            "volume": "47",
            "issn": "",
            "pages": "65--73",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Ribavirin for Crimean-Congo hemorrhagic fever: Systematic review and meta-analysis",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Soares-Weiser",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Thomson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Garner",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "BMC Infect Dis",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Ribavirin for patients with Crimean-Congo haemorrhagic fever: A systematic review and meta-analysis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ascioglu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Leblebicioglu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Vahaboglu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Chan",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Antimicrob Chemother",
            "volume": "66",
            "issn": "",
            "pages": "1215--1237",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Enria",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Briggiler",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Levis",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Vallejos",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "I"
                    ],
                    "last": "Maiztegui",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "G"
                    ],
                    "last": "Canonico",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "Antiviral Res",
            "volume": "7",
            "issn": "",
            "pages": "353--362",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Enria",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "I"
                    ],
                    "last": "Maiztegui",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "",
            "volume": "23",
            "issn": "",
            "pages": "23--31",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Treatment of Argentine hemorrhagic fever",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Enria",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Briggiler",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "S\u00e1nchez",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Antiviral Res",
            "volume": "78",
            "issn": "",
            "pages": "132--141",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Treatment of Bolivian hemorrhagic fever with intravenous ribavirin",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Kilgore",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "G"
                    ],
                    "last": "Ksiazek",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Rollin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "N"
                    ],
                    "last": "Mills",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Villagra",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Montenegro",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Clin Infect Dis",
            "volume": "24",
            "issn": "",
            "pages": "718--740",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Brief report: Treatment of a laboratory-acquired Sabi\u00e1 virus infection",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Barry",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Russi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Armstrong",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Geller",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tesh",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dembry",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "N Engl J Med",
            "volume": "333",
            "issn": "",
            "pages": "294--300",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Omrani",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Saad",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Baig",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bahloul",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Abdul-Matin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "Y"
                    ],
                    "last": "Alaidaroos",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Lancet Infect Dis",
            "volume": "14",
            "issn": "",
            "pages": "1090--1095",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "Y-J",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "H"
                    ],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "D-W",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Jeong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "BMC Infect Dis",
            "volume": "17",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "The therapeutic effect of high flow nasal cannula oxygen therapy for the first imported case of Middle East respiratory syndrome to China",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ling",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Qin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Middle East respiratory syndrome coronavirus during pregnancy",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Malik",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "El Masry",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ravi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Sayed",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Emerg Infect Dis",
            "volume": "22",
            "issn": "",
            "pages": "515--522",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Combination therapy with lopinavir/ritonavir, ribavirin and interferon-\u2423 for Middle East respiratory syndrome",
            "authors": [
                {
                    "first": "U",
                    "middle": [
                        "J"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "E-J",
                    "middle": [],
                    "last": "Won",
                    "suffix": ""
                },
                {
                    "first": "S-J",
                    "middle": [],
                    "last": "Kee",
                    "suffix": ""
                },
                {
                    "first": "Jung S-I",
                    "middle": [],
                    "last": "Jang",
                    "suffix": ""
                },
                {
                    "first": "H-C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Antivir Ther",
            "volume": "21",
            "issn": "",
            "pages": "455--464",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Spanakis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tsiodras",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Haagmans",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "S"
                    ],
                    "last": "Raj",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Pontikis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Koutsoukou",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Int J Antimicrob Agents",
            "volume": "44",
            "issn": "",
            "pages": "528--560",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Acute management and long-term survival among subjects with severe Middle East respiratory syndrome coronavirus pneumonia and ARDS",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Khalid",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Alraddadi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Dairi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "J"
                    ],
                    "last": "Khalid",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kadri",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "N"
                    ],
                    "last": "Alshukairi",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Respir Care",
            "volume": "61",
            "issn": "",
            "pages": "340--348",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "IFN-\u24232a or IFN-\u24241a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: A retrospective study",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shalhoub",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Farahat",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jiffri",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Simhairi",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Shamma",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Siddiqi",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Antimicrob Chemother",
            "volume": "70",
            "issn": "",
            "pages": "2129--2161",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): Case reports from a tertiary care hospital in Saudi Arabia",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Khalid",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Rabiah",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Alismaili",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Saleemi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Rehan-Khaliq",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Ann Saudi Med",
            "volume": "34",
            "issn": "",
            "pages": "396--400",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Ribavirin and interferon-\u24232b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: A preliminary report of two cases",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Khalid",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Rabiah",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mobeireek",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "S"
                    ],
                    "last": "Butt",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Mutairy",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Antivir Ther",
            "volume": "20",
            "issn": "",
            "pages": "87--91",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: An observational study",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Al-Tawfiq",
                    "suffix": ""
                },
                {
                    "first": "Momattin",
                    "middle": [
                        "A"
                    ],
                    "last": "Dib",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Memish",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Z"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Int J Infect Dis",
            "volume": "20",
            "issn": "",
            "pages": "42--48",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "que merece una revisi\u00f3n profunda. Se trata de una GI: gastrointestinal; IG: inmunoglobulina; i.v.: intravenosa; M: mujeres; ND: no disponible; NE: no especificado; RBV: ribavirina; V varones.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Series de casos de enfermedad por adenovirus tratada con ribavirina",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Series de casos de enfermedad por MERS-CoV tratados con ribavirina (+ IFN) Pauta A. Ribavirina (2.000 mg dosis de carga, seguido por 600 mg/12 h) + IFN-a2a (180 g/semana durante 2 semanas) o IFN-b1a (44 mg 3 v/semana). Pauta B. Ribavirina (2.000 mg dosis de carga, luego 1.200 mg/8 h durante 4 d\u00edas), seguido de 600 mg/8 h durante 4-6 d\u00edas (ajustado a funci\u00f3n renal) + IFN-a2b (180 g/semana durante 2 semanas). Pauta C. Ribavirina (2.000 mg dosis de carga, luego 1.200 mg/8 h durante 4 d\u00edas) + IFN-a2b pegilado 180 g/semana durante 2 semanas). Pauta D. Ribavirina (2.000 mg dosis de carga, luego 800 mg/8 h por sonda nasog\u00e1strica) + IFN-a2b 100 mg/semana durante 2 semanas. a Dada la heterogeneidad de los art\u00edculos, en ocasiones se describe la media o la mediana y el rango. b Todos los supervivientes tomaban la combinaci\u00f3n de RBV + IFN. c Sin diferencias en el tipo de IFN alfa o beta. Todas las series son de Arabia Saud\u00ed.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}